Michael heads up the Life Sciences & Healthcare industry group and with around 20 years of experience, he is a proven specialist and solution-oriented negotiator for complex M&A and private equity transactions. Michael takes up the challenge of complex situations in the interests of his clients.

 

His portfolio includes advice on large corporate transactions acting either on the side of the buyer or the seller, but also on restructuring, joint ventures, minority shareholdings, management investments and general corporate law issues. Michael represents the interests of strategic and financial investors from Germany and abroad, including hospital operators, medical care centre operators, medical technology and life sciences companies, and other healthcare providers - a range that reflects his strong industry expertise.

Show full CV Hide full CV

Latest news & insights

office-building-facades
Private equity

Advising The Rohatyn Group on investment in Optimapharm d.d.

22 May 2020
QUICK READ

by multiple authors

Click here to find out more
Corporate/M&A & capital markets

Taylor Wessing advises Oberberg Group on the acquisition of Panorama Fachkliniken

16 September 2019

by Michael Stein

Click here to find out more
Corporate/M&A & capital markets

Taylor Wessing advises Oberberg Group on successful refinancing

10 September 2019

by Michael Stein and Ulf Gosejacob

Click here to find out more
DNA helix
Life sciences & healthcare

Paul England writes on COVID-19 drug supply and patent system for Manufacturing Chemist

6 August 2020
QUICK READ

by Paul England, DPhil

Click here to find out more

Related people

Meet me at

There are no upcoming events